169 related articles for article (PubMed ID: 34167352)
1. Homozygous spinocerebellar ataxia type 3 in China: a case report.
Chen Y; Li D; Wei M; Zhou M; Zhang L; Yu J; Qiu M; Jin Y; Lu X
J Int Med Res; 2021 Jun; 49(6):3000605211021370. PubMed ID: 34167352
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and genetic characteristics of homozygous spinocerebellar ataxia type 3.
Li QF; Cheng HL; Yang L; Ma Y; Zhao JJ; Dong Y; Wu ZY
Mol Genet Genomic Med; 2020 Sep; 8(9):e1314. PubMed ID: 32643267
[TBL] [Abstract][Full Text] [Related]
3. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
[TBL] [Abstract][Full Text] [Related]
4. Childhood-Onset Spinocerebellar Ataxia 3: Tongue Dystonia as an Early Manifestation.
Mitchell N; LaTouche GA; Nelson B; Figueroa KP; Walker RH; Sobering AK
Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31565539
[TBL] [Abstract][Full Text] [Related]
5. RAN Translation of the Expanded CAG Repeats in the SCA3 Disease Context.
Jazurek-Ciesiolka M; Ciesiolka A; Komur AA; Urbanek-Trzeciak MO; Krzyzosiak WJ; Fiszer A
J Mol Biol; 2020 Dec; 432(24):166699. PubMed ID: 33157084
[TBL] [Abstract][Full Text] [Related]
6. Population genetics and new insight into range of CAG repeats of spinocerebellar ataxia type 3 in the Han Chinese population.
Gan SR; Ni W; Dong Y; Wang N; Wu ZY
PLoS One; 2015; 10(8):e0134405. PubMed ID: 26266536
[TBL] [Abstract][Full Text] [Related]
7. Factors Associated with Intergenerational Instability of ATXN3 CAG Repeat and Genetic Anticipation in Chinese Patients with Spinocerebellar Ataxia Type 3.
Du YC; Ma Y; Shao YR; Gan SR; Dong Y; Wu ZY
Cerebellum; 2020 Dec; 19(6):902-906. PubMed ID: 32676850
[TBL] [Abstract][Full Text] [Related]
8. APOE ε2 allele may decrease the age at onset in patients with spinocerebellar ataxia type 3 or Machado-Joseph disease from the Chinese Han population.
Peng H; Wang C; Chen Z; Sun Z; Jiao B; Li K; Huang F; Hou X; Wang J; Shen L; Xia K; Tang B; Jiang H
Neurobiol Aging; 2014 Sep; 35(9):2179.e15-8. PubMed ID: 24746364
[TBL] [Abstract][Full Text] [Related]
9. Spinocerebellar ataxia type 3/Machado-Joseph disease: segregation patterns and factors influencing instability of expanded CAG transmissions.
Souza GN; Kersting N; Krum-Santos AC; Santos AS; Furtado GV; Pacheco D; Gonçalves TA; Saute JA; Schuler-Faccini L; Mattos EP; Saraiva-Pereira ML; Jardim LB
Clin Genet; 2016 Aug; 90(2):134-40. PubMed ID: 26693702
[TBL] [Abstract][Full Text] [Related]
10. Variation in DNA Repair System Gene as an Additional Modifier of Age at Onset in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
Mergener R; Furtado GV; de Mattos EP; Leotti VB; Jardim LB; Saraiva-Pereira ML
Neuromolecular Med; 2020 Mar; 22(1):133-138. PubMed ID: 31587151
[TBL] [Abstract][Full Text] [Related]
11. Selective forces acting on spinocerebellar ataxia type 3/Machado-Joseph disease recurrency: A systematic review and meta-analysis.
Sena LS; Dos Santos Pinheiro J; Saraiva-Pereira ML; Jardim LB
Clin Genet; 2021 Mar; 99(3):347-358. PubMed ID: 33219521
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of PNKP by mutant ATXN3 triggers apoptosis by activating the DNA damage-response pathway in SCA3.
Gao R; Liu Y; Silva-Fernandes A; Fang X; Paulucci-Holthauzen A; Chatterjee A; Zhang HL; Matsuura T; Choudhary S; Ashizawa T; Koeppen AH; Maciel P; Hazra TK; Sarkar PS
PLoS Genet; 2015 Jan; 11(1):e1004834. PubMed ID: 25590633
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9-Targeted Deletion of Polyglutamine in Spinocerebellar Ataxia Type 3-Derived Induced Pluripotent Stem Cells.
Ouyang S; Xie Y; Xiong Z; Yang Y; Xian Y; Ou Z; Song B; Chen Y; Xie Y; Li H; Sun X
Stem Cells Dev; 2018 Jun; 27(11):756-770. PubMed ID: 29661116
[TBL] [Abstract][Full Text] [Related]
14. Prenatal diagnosis of Machado-Joseph disease/Spinocerebellar Ataxia Type 3 in Taiwan: early detection of expanded ataxin-3.
Tsai HF; Liu CS; Chen GD; Lin ML; Li C; Chen YY; Wang BT; Hsieh M
J Clin Lab Anal; 2003; 17(5):195-200. PubMed ID: 12938149
[TBL] [Abstract][Full Text] [Related]
15. [Analysis and application of SCA1 and SCA3/MJD gene CAG repeats in Han population in Northeastern China].
Jiang M; Jin CL; Lin CK; Qiu GR; Liu ZL; Wang CX; Sun KL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):83-5. PubMed ID: 14767919
[TBL] [Abstract][Full Text] [Related]
16. Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein.
Ashraf NS; Sutton JR; Yang Y; Ranxhi B; Libohova K; Shaw ED; Barget AJ; Todi SV; Paulson HL; Costa MDC
Neurobiol Dis; 2020 Apr; 137():104697. PubMed ID: 31783119
[TBL] [Abstract][Full Text] [Related]
17. High Serum GFAP Levels in SCA3/MJD May Not Correlate with Disease Progression.
Shi Y; Wang C; Huang F; Chen Z; Sun Z; Wang J; Tang B; Ashizawa T; Klockgether T; Jiang H
Cerebellum; 2015 Dec; 14(6):677-81. PubMed ID: 25869927
[TBL] [Abstract][Full Text] [Related]
18. [Clinical features and gene mutation analysis in Machado-Joseph disease of spinocerebellar ataxia type 3 in littoral of Zhejiang].
Jin YY; Zeng AP; Cai HB; Wu F; Feng Z; Hong Q; Zhang L; Jiang ZK
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Apr; 23(2):132-4. PubMed ID: 20104758
[TBL] [Abstract][Full Text] [Related]
19. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.
Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M
Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414
[TBL] [Abstract][Full Text] [Related]
20. CAG Repeat Size Influences the Progression Rate of Spinocerebellar Ataxia Type 3.
Leotti VB; de Vries JJ; Oliveira CM; de Mattos EP; Te Meerman GJ; Brunt ER; Kampinga HH; Jardim LB; Verbeek DS
Ann Neurol; 2021 Jan; 89(1):66-73. PubMed ID: 32978817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
